Skip to main content

People in the News: Mark Boguski, Matthew Beer, Harry Hixson, Paul Billings, and More


Mark Boguski, a faculty member of Harvard Medical School and Beth Israel Deaconess Medical Center, has founded Genome Health Solutions, a new company focused on personalized genomic medicine.

The company offers genomic medicine consulting for hospital systems and other healthcare delivery organizations as well as assistance with diagnostic and information technology selection, management, and optimization. It also helps with the design and management of specific cancer genome/transcriptome analyses versus standard-of-care molecular diagnostics; provides individual case management; and helps with the management of medical social media channels for patient/physician education, marketing, and communication.

Boguski has previously held faculty positions at the Johns Hopkins University School of Medicine; the National Institutes of Health; the National Library of Medicine; and has served as an executive in the biotechnology and pharmaceutical industries, including as a former vice president of Novartis.

Sequenom said in a document filed with the US Securities and Exchange Commission that shareholders re-elected its board of directors to hold office until the annual meeting next year. Those re-elected are Ernst Günter Afting; Kenneth Buechler; John Fazio; Harry Hixson; Richard Lerner; Ronald Lindsay; David Pendarvis; and Charles Slacik.

Transgenomic has appointed Matthew Beer as vice president of business development for oncology.

Beer was previously director of oncology marketing and hematology/oncology life cycle leader at Quest Diagnostics. Prior to that, he was vice president of business development at Caris Life Sciences. He has also worked for Abbott, Targeted Molecular Diagnostics, and Oncotech. He holds a BS in microbiology from the University of Iowa. has appointed Paul Billings to its board of directors. Billings has also been named a member of the company's audit committee.

Billings is currently chief medical officer at Life Technologies. He also was CEO of Cellective Dx and senior vice president of Laboratory Corporation of America.

Genomic Health
shareholders have re-elected the company's board of directors, including Julian Baker; Fred Cohen; Samuel Colella; Ginger Graham; Randall Livingston; Woodrow Myers; Kimberly Popovits; and Randal Scott.
The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.